Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Listen now
Description
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 3/29/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
Did you know agitation is a treatable entity among patients with Alzheimer’s disease? Learn about potential causes and treatments for agitation.
Credit available for this activity expires: 10/29/25
Earn Credit / Learning Objectives & Disclosures:...
Published 10/29/24
Published 10/29/24
Top tips for informed conversations with patients and their families around this new class of drugs for Alzheimer’s disease (AD).
Credit available for this activity expires: 10/28/25
Earn Credit / Learning Objectives & Disclosures: ...
Published 10/29/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
